Pricing Log in Create free account

Equillium, Inc. (EQ) vs Neumora Therapeutics, Inc. (NMRA)

Equillium, Inc. and Neumora Therapeutics, Inc. are both Biotechnology companies. Equillium, Inc. and Neumora Therapeutics, Inc. are of similar size ($91.3M and $90.2M). Across the 10 metrics below, Equillium, Inc. leads on 7 and Neumora Therapeutics, Inc. on 3.

Valuation

Metric EQ NMRA Biotechnology median
P/E n/m n/m 8.68
P/S 3.89 n/m 10.29
P/B 2.85 2.00 2.40
Price to free cash flow n/m n/m 20.52
EV/EBITDA n/m n/m 0.68
EV/Sales 2.68 n/m 10.15
Earnings yield (13.99%) (256.25%) (28.86%)
Free cash flow yield (12.56%) (202.88%) (22.44%)

Profitability

Metric EQ NMRA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (58.98%) (187.11%) (56.66%)
Return on assets (50.68%) (121.89%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EQ NMRA Biotechnology median
Revenue growth (TTM) 13.89% — 5.64%
EPS growth (last fiscal year) (69.57%) 5.23% 30.08%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric EQ NMRA Biotechnology median
Debt to equity 0.00 1.19 0.00
Current ratio 23.40 4.50 4.72
Net debt to EBITDA 1.29 0.53 0.96

Dividend

Metric EQ NMRA Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric EQ NMRA Biotechnology median
Market cap 91.31m 90.15m 150.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack